These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30796300)

  • 61. Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
    Neven E; Opdebeeck B; De Maré A; Bashir-Dar R; Dams G; Marynissen R; Behets GJ; Verhulst A; Riser BL; D'Haese PC
    Calcif Tissue Int; 2016 Nov; 99(5):525-534. PubMed ID: 27461215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
    Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Yamada S; Leaf EM; Chia JJ; Cox TC; Speer MY; Giachelli CM
    Kidney Int; 2018 Oct; 94(4):716-727. PubMed ID: 30041812
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.
    Alesutan I; Feger M; Tuffaha R; Castor T; Musculus K; Buehling SS; Heine CL; Kuro-O M; Pieske B; Schmidt K; Tomaschitz A; Maerz W; Pilz S; Meinitzer A; Voelkl J; Lang F
    Cardiovasc Res; 2016 Jun; 110(3):408-18. PubMed ID: 27001421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quercetin Attenuates Vascular Calcification through Suppressed Oxidative Stress in Adenine-Induced Chronic Renal Failure Rats.
    Chang XY; Cui L; Wang XZ; Zhang L; Zhu D; Zhou XR; Hao LR
    Biomed Res Int; 2017; 2017():5716204. PubMed ID: 28691026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor.
    Masumoto A; Sonou T; Ohya M; Yashiro M; Nakashima Y; Okuda K; Iwashita Y; Mima T; Negi S; Shigematsu T
    J Atheroscler Thromb; 2017 Jul; 24(7):716-724. PubMed ID: 27840385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation.
    O'Neill WC; Adams AL
    Kidney Int; 2014 Mar; 85(3):668-76. PubMed ID: 24048381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals.
    Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of CEM calcification by the sequential pretreatment with ethanol and EDTA.
    Singla A; Lee CH
    J Biomed Mater Res A; 2003 Mar; 64(4):706-13. PubMed ID: 12601783
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
    Zaragatski E; Grommes J; Schurgers LJ; Langer S; Kennes L; Tamm M; Koeppel TA; Kranz J; Hackhofer T; Arakelyan K; Jacobs MJ; Kokozidou M
    Kidney Int; 2016 Mar; 89(3):601-11. PubMed ID: 26466318
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation?
    Ter Braake AD; Shanahan CM; de Baaij JHF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1431-1445. PubMed ID: 28663256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.
    Leenders NHJ; Bos C; Hoekstra T; Schurgers LJ; Vervloet MG; Hoenderop JGJ
    Nephrol Dial Transplant; 2022 May; 37(6):1049-1058. PubMed ID: 35134986
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease.
    Zelt JG; McCabe KM; Svajger B; Barron H; Laverty K; Holden RM; Adams MA
    J Pharmacol Exp Ther; 2015 Dec; 355(3):451-62. PubMed ID: 26487689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic kidney disease results in deficiency of ABCC6, the novel inhibitor of vascular calcification.
    Lau WL; Liu S; Vaziri ND
    Am J Nephrol; 2014; 40(1):51-5. PubMed ID: 24994603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification.
    Du Y; Gao C; Liu Z; Wang L; Liu B; He F; Zhang T; Wang Y; Wang X; Xu M; Luo GZ; Zhu Y; Xu Q; Wang X; Kong W
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2580-8. PubMed ID: 22995515
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?
    Hildebrand S; Cunningham J
    Bone; 2021 Jan; 142():115751. PubMed ID: 33188959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.